Related Experiment Video

Updated: Jun 6, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1

Kazuki Ohno1, Yasushi Amano, Hirotoshi Kakuta

  • 1Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Japan.

Biochemical and Biophysical Research Communications
|December 7, 2010
PubMed

Insights

Telmisartan exhibits superior blood pressure reduction compared to other Angiotensin II type 1 receptor blockers (ARBs). Its unique "delta lock" structure enhances binding affinity, potentially offering better cardiovascular protection in hypertensive patients.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Angiotensin II type 1 receptor blockers (ARBs) are widely used antihypertensive agents.
  • Effective blood pressure (BP) control is crucial for organ protection in hypertension.
  • Telmisartan has shown potential as the strongest ARB for BP reduction in essential hypertension.

Purpose of the Study:

  • To elucidate the molecular interactions of telmisartan with the AT1 receptor that contribute to its potent BP-lowering activity.
  • To compare the binding modes of telmisartan with other ARBs at the molecular level.

Main Methods:

  • Construction of molecular models for ARB-AT1 receptor interactions.
  • Comparative docking analysis of telmisartan and other ARBs.

Main Results:

  • Telmisartan displays a unique binding mode to the AT1 receptor, attributed to its distal benzimidazole portion.
  • This unique structure correlates with higher molecular lipophilicity, greater volume distribution, and stronger binding affinity.
  • A distinctive "delta lock" structure was identified for telmisartan's firm binding to the AT1 receptor.

Conclusions:

  • Telmisartan's unique "delta lock" structure may explain its superior efficacy in lowering BP compared to other ARBs.
  • This enhanced binding could position telmisartan as a more effective agent for preventing cardiovascular disease in hypertensive individuals.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...